ArticleCancer medicine2023
Sustainable return to work among breast cancer survivors.
Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 15 citations in OpenAlex.
- "Rebuilding Myself"- An intervention enhancing adaptability of cancer patients to return to work: a feasibility study.Revista da Escola de Enfermagem da U S P · 2025Trial
- Return to work and cancer survivorship needs of breast cancer survivors: an observational prospective single-cohort study in Italy.Scientific reports · 2026Observational
- Returning to work after breast cancer diagnosis: a cross-sectional study of socioeconomic and clinical factors associated with return to work in Luxembourg.BMC women's health · 2026Observational
- The long road after breast cancer: survivorship issues and long-term treatment effects in young women.Frontiers in oncology · 2026Review
- Latent profile analysis of return-to-work readiness and self-efficacy among breast cancer survivors who have not returned to work post-surgery.Journal of cancer survivorship : research and practice · 2025Article
- Breast cancer survivors' participation in social activities five years after primary surgery - are there social inequalities?BMC cancer · 2025Article
- Predictors of return-to-work after thyroid cancer surgery based on random forest model: a cross-sectional study.BMC surgery · 2025Article
- Return to work or leaving work? Differences of return to work between breast cancer patients and the general population and determinants of return to work.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Observational
- Experiences of healthcare professionals returning to work post breast cancer diagnosis in China: A descriptive qualitative study.Scientific reports · 2025Article
- Returning to Work after Breast Cancer: A One-Year Mixed-Methods Study.International journal of environmental research and public health · 2024Article
- Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis.JAMA network open · 2024Article
- Sustainable return to work among breast cancer survivors.Cancer medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 11 institutions in 1 country.
Funding
Abstract
purposeThis study assessed sustainable return to work (SRTW) of breast cancer survivors (BCS).
methodsWe used data from the prospective French cohort, CANTO. We included 1811 stage I-III BCS who were <57 years old and employed at the moment of diagnosis and working 2 years after diagnosis. Using logistic regression, we investigated the role of clinical, health and socio-economic factors, and the work environment on SRTW 3 years after diagnosis. We compared having any sick leave with having worked continuously and being unemployed to having worked continuously between 2 and 3 years after diagnosis.
resultsOverall, 77% (n = 1395) worked continuously after return to work (RTW). Out of the other 416 BCS, 66% had any sick leave period, 33% had been unemployed, 4% had an early retirement, 2% a disability and 1% another status (multiple situations possible). Being on sick leave was associated with age > 50 (OR = 0.59; 95%CI = 0.43-0.82), stage III (2.56; 1.70-3.85), tumour subtype HR+/HER2+ (0.61; 0.39-0.95), severe fatigue (1.45; 1.06-1.98), workplace accommodations (1.63; 1.14-2.33) and life priorities (0.71; 0.53-0.95). Unemployment was associated with age > 50 (0.45; 0.29-0.72), working in the public sector (0.31; 0.19-0.51), for a small company (3.00; 1.74-5.20) and having a fixed-term contract (7.50; 4.74-11.86).
conclusionsA high number of BCS have periods of sick leave or unemployment after RTW. The determinants differ between sick leave and unemployment. IMPLICATIONS FOR CANCER SURVIVORS: BCS need to be supported even after RTW, which should be regarded as a process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.